194 related articles for article (PubMed ID: 4579393)
21. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
22. A double blind comparative trial of pericyazine and thioridazine in chronic schizophrenia.
Barker JC; Miller M
Br J Psychiatry; 1969 Feb; 115(519):169-72. PubMed ID: 4888133
[No Abstract] [Full Text] [Related]
23. A fulminant case of neuroleptic malignant syndrome.
Teo SK; Lam KN; Chew WL
Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269
[TBL] [Abstract][Full Text] [Related]
24. Thioridazine as an antidepressant.
Practitioner; 1972 Jul; 209(249):95-8. PubMed ID: 4557482
[No Abstract] [Full Text] [Related]
25. Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics.
Pacquay M; Brasseur F
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):46-9. PubMed ID: 798190
[TBL] [Abstract][Full Text] [Related]
26. Intermittent pharmacotherapy in chronic schizophrenia.
Prien RF; Gillis RD; Caffey EM
Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
[No Abstract] [Full Text] [Related]
27. Pimozide in chronic schizophrenic patients.
Huber W; Serafetinides EA; Colmore JP; Clark M
J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
[No Abstract] [Full Text] [Related]
28. Use of haloperidol in a "hard-core" chronic schizophrenic population.
Lee H
Psychosomatics; 1968; 9(5):267-71. PubMed ID: 4879677
[No Abstract] [Full Text] [Related]
29. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Paprocki J; Versiani M
Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
[No Abstract] [Full Text] [Related]
30. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
[No Abstract] [Full Text] [Related]
31. Thiothixene, thioridazine, and placebo in male chronic schizophrenic patients.
Wolpert A; Sheppard C; Merlis S
Clin Pharmacol Ther; 1968; 9(4):456-64. PubMed ID: 4871899
[No Abstract] [Full Text] [Related]
32. [The effects of thioridazine, flupenthixol and haloperidol on serum catalase activity in schizophrenia].
Zapletálek M
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1977; 20(2-3):197-204. PubMed ID: 305641
[No Abstract] [Full Text] [Related]
33. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Martin IC
Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
[TBL] [Abstract][Full Text] [Related]
34. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
Saletu B; Saletu M; Itil T; Marasa J
Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
[No Abstract] [Full Text] [Related]
35. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
[TBL] [Abstract][Full Text] [Related]
36. Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics.
Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
Compr Psychiatry; 1978; 19(6):517-25. PubMed ID: 720036
[No Abstract] [Full Text] [Related]
37. Electrocardiographic evaluation of thiothixene: a double-blind comparison with thioridazine.
Dillenkoffer RL; George RB; Bishop MP; Gallant DM
Adv Biochem Psychopharmacol; 1974; 9(0):487-95. PubMed ID: 4599436
[No Abstract] [Full Text] [Related]
38. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
Breuning SE; Ferguson DG; Cullari S
Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
[No Abstract] [Full Text] [Related]
39. Gradual reduction of neuroleptic drugs among chronic schizophrenics. A double-blind controlled study.
Lonowski DJ; Sterling FE; Kennedy JC
Acta Psychiatr Scand; 1978 Feb; 57(2):97-102. PubMed ID: 345749
[TBL] [Abstract][Full Text] [Related]
40. Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia.
Gerlach J; Koppelhus P; Helweg E; Monrad A
Acta Psychiatr Scand; 1974; 50(4):410-24. PubMed ID: 4153596
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
